SFRS2IP expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.956000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.001000E-01
Normal-vs-Stage2
6.124100E-02
Normal-vs-Stage3
2.021600E-01
Normal-vs-Stage4
5.924400E-01
Stage1-vs-Stage2
5.615600E-01
Stage1-vs-Stage3
4.116700E-03
Stage1-vs-Stage4
5.877600E-01
Stage2-vs-Stage3
8.264200E-02
Stage2-vs-Stage4
3.181600E-01
Stage3-vs-Stage4
3.890100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.451800E-02
Normal-vs-AfricanAmerican
4.240800E-01
Normal-vs-Asian
1.266990E-01
Caucasian-vs-AfricanAmerican
4.349800E-01
Caucasian-vs-Asian
4.914600E-01
AfricanAmerican-vs-Asian
3.822200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.744300E-02
Normal-vs-Female
5.773600E-02
Male-vs-Female
6.373600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.167000E-01
Normal-vs-Age(41-60Yrs)
2.036000E-01
Normal-vs-Age(61-80Yrs)
2.700000E-02
Normal-vs-Age(81-100Yrs)
3.173200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.417800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.208400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.794800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.639900E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.158100E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.144400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.504000E-01
Normal-vs-Daily Drinker
2.921400E-01
Normal-vs-Weekly Drinker
8.295700E-02
Normal-vs-Occasional Drinker
2.233600E-01
Normal-vs-Social Drinker
2.353200E-01
Non Drinker-vs-Daily Drinker
3.273000E-01
Non Drinker-vs-Weekly Drinker
6.970600E-01
Non Drinker-vs-Occasional Drinker
1.677010E-01
Non Drinker-vs-Social Drinker
2.520200E-01
Daily Drinker-vs-Weekly Drinker
7.203800E-01
Daily Drinker-vs-Occasional Drinker
4.281600E-02
Daily Drinker-vs-Social Drinker
7.689800E-02
Weekly Drinker-vs-Occasional Drinker
1.925960E-01
Weekly Drinker-vs-Social Drinker
2.654800E-01
Occasional Drinker-vs-Social Drinker
9.098800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.426400E-02
Normal-vs-Grade 2
3.383700E-02
Normal-vs-Grade 3
1.323730E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.615800E-01
Grade 1-vs-Grade 3
7.307200E-01
Grade 1-vs-Grade 4
9.426400E-02
Grade 2-vs-Grade 3
7.776200E-01
Grade 2-vs-Grade 4
3.383700E-02
Grade 3-vs-Grade 4
1.323730E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.604600E-01
Normal-vs-NonDiabetic
3.568400E-01
Diabetic-vs-NonDiabetic
9.757600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.049400E-01
Normal-vs-NoPancreatitis
3.262000E-02
Pancreatitis-vs-NoPancreatitis
3.601400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.332200E-02
Normal-vs-N1
6.164500E-02
N0-vs-N1
5.580600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.315780E-01
Normal-vs-TP53-NonMutant
1.865190E-01
TP53-Mutant-vs-TP53-NonMutant
5.295800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
